Small companies that have failed to deliver
Article Abstract:
Stocks in small UK companies were forecast to perform well in 1997, but after the first three months of the year they have not performed as well a larger companies. This is partly because the sectors that are performing well, pharmaceuticals, retail banking, utilities and integrated petroleum operations, are the domain of larger firms rather than smaller firms. Smaller firms could perform better in later 1997 but a strong pound sterling has meant that they have to compete against cheaper imports. Smaller firms could offer good value if larger firms cease to climb, though there is a danger that investors could lose interest in both large and small firms.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Bad news about market stability
Article Abstract:
The volatility of the FTSE 100 index has dropped and this means that equities appear to be more secure as an investment. The world economy is less under threat from deflation and recession and there is also less uncertainty about UK interest rates. There is a lack of consensus as to which types of stocks are likely to perform well, and this has affected volatility. There is still a risk that a crash could occur, and volatility itself can vary over time.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Power companies vie for the right to swallow water. Water industry: Byatt may stay
- Abstracts: US import finds fame and fortune in UK. Banks cash in on a profitable niche. Clearing banks shape up and slim down
- Abstracts: Sales are testimony to wide appeal. The many uses of a unit trust. Competition forces costs down
- Abstracts: Gas break-up raises fears for the future. Claws out in gas contract dispute. Gas market: spoiling for a fight
- Abstracts: Merger of the medicines. Moving into the American market. Client care and feeding